ENDO-DCIEvaluation of D-Chiro-Inositol Treatment in Women With Endometriosis
D-Chiro-Inositol
+ Placebo
Urogenital Diseases+3
+ Genital Diseases
+ Endometriosis
Treatment Study
Summary
Study start date: April 15, 2024
Actual date on which the first participant was enrolled.This clinical trial is focused on finding a new way to help women with endometriosis, a condition where tissue similar to the lining inside the uterus grows outside of it. Currently, the main treatment involves surgery to remove the lesions caused by endometriosis. However, these lesions can come back, often due to high levels of estrogen, a hormone in the body. While medications that balance estrogen levels exist, they can act as contraceptives and have side effects that many women find undesirable. This study aims to explore the potential of D-Chiro-Inositol, a naturally occurring compound in the body, as a supplement to reduce estrogen levels and prevent the return of endometriosis symptoms, while still allowing women to maintain their fertility. Participants in the study will take D-Chiro-Inositol as a dietary supplement. The goal is to observe if this supplement can effectively lower estrogen levels in the body, which might help reduce the recurrence of endometriosis and ease its symptoms. By focusing on a natural molecule like D-Chiro-Inositol, the study seeks to provide an alternative treatment option that is well tolerated and does not interfere with a woman's ability to become pregnant. The trial will monitor changes in estrogen levels and any improvements in endometriosis symptoms to evaluate the effectiveness of this approach.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.64 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 18 to 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location